Easton Pharmaceuticals (EAPH) Stock Price & Analysis
EAPH Stock Chart & Stats
$0.00$0.00(0.00%)
At close: 9:30 AM EDT
- Day’s Range
- $0.01 - $0.01
- 52-Week Range
- N/A
- Previous Close
- $0.01
- Volume
- N/A
- Average Volume (3M)
- 7.47M
- Market Cap
- $1,345
- Enterprise Value
- -$23187.50T
- Total Cash (Recent Filing)
- $0
- Total Debt (Recent Filing)
- $2.84M
- Price to Earnings (P/E)
- ―
- Beta
- 16.53
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
EAPH FAQ
What is Easton Pharmaceuticals’s market cap?
Easton Pharmaceuticals’s market cap is $1,345.
When is Easton Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Easton Pharmaceuticals’s earnings last quarter?
Easton Pharmaceuticals released its earnings results on Jun 13, 2019. The company reported $0 earnings per share for the quarter.
Is Easton Pharmaceuticals overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Easton Pharmaceuticals pay dividends?
Easton Pharmaceuticals does not currently pay dividends.
What is Easton Pharmaceuticals’s EPS estimate?
Easton Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Easton Pharmaceuticals have?
Easton Pharmaceuticals has 1,344,933,000 shares outstanding.
What happened to Easton Pharmaceuticals’s price movement after its last earnings report?
Easton Pharmaceuticals reported an EPS of $0 in its last earnings report. Following the earnings report the stock price went same ―.
Which hedge fund is a major shareholder of Easton Pharmaceuticals?
Currently, no hedge funds are holding shares in EAPH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Easton Pharmaceuticals
Currently, Parallel Industries Inc. does not conduct substantial business operations. Historically, the company was involved in developing and commercializing various topically applied medications to treat cancer, alongside other therapeutic solutions for a range of medical conditions. Its strategic emphasis has typically covered the entire pharmaceutical process: from development and licensing to manufacturing and marketing of both prescription and over-the-counter products. Established in 1997, the firm is headquartered in Toronto, Canada, and was formerly known as Easton Pharmaceuticals Inc. before rebranding as Parallel Industries Inc. in December 2020.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Evan Karras
- Employees
- 6
- Website
- www.eastonpharma.com
- Address
- CA
Easton Pharmaceuticals (EAPH) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 4 | 3 |
| Technical Analysis | 3 | 2 | 1 |
| Moving Averages | 2 | 2 | 2 |
